Literature DB >> 21565376

Decreased Fc receptor expression on innate immune cells is associated with impaired antibody-mediated cellular phagocytic activity in chronically HIV-1 infected individuals.

Anne-Sophie Dugast1, Andrew Tonelli, Christoph T Berger, Margaret E Ackerman, Gaia Sciaranghella, Qingquan Liu, Magdalena Sips, Ildiko Toth, Alicja Piechocka-Trocha, Musie Ghebremichael, Galit Alter.   

Abstract

In addition to neutralization, antibodies mediate other antiviral activities including antibody-dependent cellular phagocytosis (ADCP), antibody-dependent cellular cytotoxicity (ADCC), as well as complement deposition. While it is established that progressive HIV infection is associated with reduced ADCC and ADCP, the underlying mechanism for this loss of function is unknown. Here we report considerable changes in FcR expression over the course of HIV infection on both mDCs and monocytes, including elevated FcγRI expression in acute HIV infection and reduced expression of FcγRII and FcγRIIIa in chronic HIV infection. Furthermore, selective blockade of FcγRII alone was associated with a loss in ADCP activity, suggesting that FcγRII plays a central role in modulating ADCP. Overall, HIV infection is associated with a number of changes in FcR expression on phagocytic cells that are associated with changes in their ability to respond to antibody-opsonized targets, potentially contributing to a failure in viral clearance in progressive HIV-1 infection.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21565376      PMCID: PMC3112178          DOI: 10.1016/j.virol.2011.03.012

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  47 in total

1.  Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines.

Authors:  L Pricop; P Redecha; J L Teillaud; J Frey; W H Fridman; C Sautès-Fridman; J E Salmon
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

2.  Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection.

Authors:  Galit Alter; Nickolas Teigen; Benjamin T Davis; Marylyn M Addo; Todd J Suscovich; Michael T Waring; Hendrik Streeck; Mary N Johnston; Kyle D Staller; M Tauheed Zaman; Xu G Yu; Mathias Lichterfeld; Nesli Basgoz; Eric S Rosenberg; Marcus Altfeld
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

3.  Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells.

Authors:  D N Forthal; G Landucci; E S Daar
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 4.  Role of macrophages in the pathogenesis of human immunodeficiency virus (HIV) infection.

Authors:  S M Crowe
Journal:  Aust N Z J Med       Date:  1995-12

5.  TGF-beta 1 suppresses [correction of supresses] myeloid Fc gamma receptor function by regulating the expression and function of the common gamma-subunit.

Authors:  Susheela Tridandapani; Richard Wardrop; Christopher P Baran; Yijie Wang; Judy M Opalek; Michael A Caligiuri; Clay B Marsh
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

6.  Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type 1 infection.

Authors:  Marlén M I Aasa-Chapman; Sophie Holuigue; Keith Aubin; Mailee Wong; Nicola A Jones; David Cornforth; Pierre Pellegrino; Philippa Newton; Ian Williams; Persephone Borrow; Aine McKnight
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

7.  Antibody dependent cellular cytotoxicity (ADCC)-reaction and an in vitro steroid sensitivity test of peripheral lymphocytes in children with malignant haematological and autoimmune diseases.

Authors:  A László; I Petri; M Ilyés
Journal:  Acta Paediatr Hung       Date:  1986

8.  Lipopolysaccharide and interleukin 1 inhibit interferon-gamma-induced Fc receptor expression on human monocytes.

Authors:  W P Arend; J T Ammons; B L Kotzin
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

9.  Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.

Authors:  M A Caligiuri; C Murray; M J Robertson; E Wang; K Cochran; C Cameron; P Schow; M E Ross; T R Klumpp; R J Soiffer
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

10.  Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection.

Authors:  Qingquan Liu; Yongtao Sun; Suzannah Rihn; Anne Nolting; Peter Nicholas Tsoukas; Stephanie Jost; Kristen Cohen; Bruce Walker; Galit Alter
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

View more
  43 in total

1.  Fc Receptor-Mediated Activities of Env-Specific Human Monoclonal Antibodies Generated from Volunteers Receiving the DNA Prime-Protein Boost HIV Vaccine DP6-001.

Authors:  Matthew R Costa; Justin Pollara; Regina Whitney Edwards; Michael S Seaman; Miroslaw K Gorny; David C Montefiori; Hua-Xin Liao; Guido Ferrari; Shan Lu; Shixia Wang
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

2.  Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication.

Authors:  Zelda Euler; Galit Alter
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

3.  Enhanced phagocytic activity of HIV-specific antibodies correlates with natural production of immunoglobulins with skewed affinity for FcγR2a and FcγR2b.

Authors:  Margaret E Ackerman; Anne-Sophie Dugast; Elizabeth G McAndrew; Stephen Tsoukas; Anna F Licht; Darrell J Irvine; Galit Alter
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

Review 4.  Role of Fc-mediated antibody function in protective immunity against HIV-1.

Authors:  George K Lewis
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

5.  Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection.

Authors:  Derseree Archary; Rong Rong; Michelle L Gordon; Saikat Boliar; Maphuti Madiga; Elin S Gray; Anne-Sophie Dugast; Tandile Hermanus; Philip J R Goulder; Hoosen M Coovadia; Lise Werner; Lynn Morris; Galit Alter; Cynthia A Derdeyn; Thumbi Ndung'u
Journal:  Virology       Date:  2012-09-18       Impact factor: 3.616

6.  Monoclonal Antibodies Specific for the V2, V3, CD4-Binding Site, and gp41 of HIV-1 Mediate Phagocytosis in a Dose-Dependent Manner.

Authors:  Thomas Musich; Liuzhe Li; Lily Liu; Susan Zolla-Pazner; Marjorie Robert-Guroff; Miroslaw K Gorny
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

Review 7.  Opportunities to exploit non-neutralizing HIV-specific antibody activity.

Authors:  Margaret E Ackerman; Galit Alter
Journal:  Curr HIV Res       Date:  2013-07       Impact factor: 1.581

8.  Fc receptor-mediated immune responses: new tools but increased complexity in HIV prevention.

Authors:  Diego A Vargas-Inchaustegui; Marjorie Robert-Guroff
Journal:  Curr HIV Res       Date:  2013-07       Impact factor: 1.581

9.  Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function.

Authors:  Amy W Chung; Max Crispin; Laura Pritchard; Hannah Robinson; Miroslaw K Gorny; Xiaojie Yu; Chris Bailey-Kellogg; Margaret E Ackerman; Chris Scanlan; Susan Zolla-Pazner; Galit Alter
Journal:  AIDS       Date:  2014-11-13       Impact factor: 4.177

10.  Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk.

Authors:  Scott D Neidich; Youyi Fong; Shuying S Li; Daniel E Geraghty; Brian D Williamson; William Chad Young; Derrick Goodman; Kelly E Seaton; Xiaoying Shen; Sheetal Sawant; Lu Zhang; Allan C deCamp; Bryan S Blette; Mengshu Shao; Nicole L Yates; Frederick Feely; Chul-Woo Pyo; Guido Ferrari; Ian Frank; Shelly T Karuna; Edith M Swann; John R Mascola; Barney S Graham; Scott M Hammer; Magdalena E Sobieszczyk; Lawrence Corey; Holly E Janes; M Juliana McElrath; Raphael Gottardo; Peter B Gilbert; Georgia D Tomaras
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.